salgador.jpg Salgado R
Columnista Experta de SIIC


MD, Pathology, Antwerp, Bélgica
HEMOSTASIA Y ANGIOGENESIS EN CANCER: POSIBLE NUEVO PAPEL DE LA INTERLEUQUINA 6
Columnista Experta de SIIC Salgado R en colaboración con Peter Vermeulen , MD, PhD. Department of Pathology, AZ. ST.-Augustinus Hospital, Oosterveldlaan 24-26. 2610 Wilrijk, Antwerp, Belgium.; Luc Y. Dirix , MD, PhD, Oncology Center, AZ. ST.-Augustinus Hospital, Oosterveldlaan 24-26 2610 Wilrijk, Antwerp, Belgium


Primera edición en siicsalud: 7 de julio, 2004
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/66654  
Especialidad principal: Especialidad principalOncología

Especialidades relacionadas:
Farmacología,Hematología,Inmunología,Medicina Interna,

  • R.Salgado, I. Benoy, R. Weytjens, D. Van Bockstaele, E. Van Marck, Ph. Huget, M. Hoylaerts, P. Vermeulen, LY. Dirix. Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer., British Journal of Cancer 87(87):1437-1444

  • Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours., European Journal of Cancer 38(38):1564-1569

  • Dirix LY., Van Oosterom A. Gene-expression profiling to classify soft-tissue sarcomas., Lancet 359(359):1263-1264

  • R. Salgado, P. Vermeulen, I. Benoy, R. Weytjens, Ph. Huget, E. Van Marck, LY. Dirix. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients., British Journal of Cancer 80(80):892-897

  • Vermeulen PB, Van den Eynden GG, Huget P, Goovaerts G, Weyler J, Lardon F, Van Marck E, Hubens G, Dirix LY. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer, British Journal of Cancer 79(79):316-322

  • Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer., Clinical Cancer Research 4(4):2625-2634

  • Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy I, De Pooter C, Martin M, Van Oosterom AT. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients., British Journal of Cancer 76(76):238-243

  • Vermeulen PB., Libura M., Libura J., O`Nelly PJ, van Dam P., Van Marck E., Van Oosterom AT., Dirix LY. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma., Breast Cancer Research and Treatment 42(42):165-172

  • Vermeulen PB, Dirix LY, Martin M, Lemmens J, Van Oosterom AT. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b., Journal of the National Cancer Institute 89(89):1316-1317


  • Salgado R

    ua40317